These innovative treatments , including Rybelsus, belong to a category of drugs called GLP-1 agents. Initially intended for treating type 2 diabetes , they operate by assisting the pancreas to release adequate the hormone insulin and limiting high sugar levels. Beyond diabetes, their ability to encourage weight loss has resulted to significant inte